Bridger Management LLC Acquires Shares of 23,699 UnitedHealth Group Incorporated $UNH

Bridger Management LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the second quarter, HoldingsChannel.com reports. The firm purchased 23,699 shares of the healthcare conglomerate’s stock, valued at approximately $9,850,000. UnitedHealth Group makes up approximately 6.6% of Bridger Management LLC’s investment portfolio, making the stock its 4th biggest holding.

Other institutional investors have also recently bought and sold shares of the company. Norges Bank acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $4,376,167,000. Corient Private Wealth LP bought a new stake in UnitedHealth Group during the 2nd quarter worth about $245,516,000. Legal & General Group Plc bought a new position in shares of UnitedHealth Group in the second quarter worth about $2,444,928,000. Jupiter Topco LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $2,019,844,000. Finally, BlackRock Inc. raised its position in UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after purchasing an additional 3,395,530 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $393.99 on Friday. The firm has a market capitalization of $353.64 billion, a P/E ratio of 25.35, a PEG ratio of 1.36 and a beta of 0.62. The business has a 50-day moving average of $413.28 and a 200-day moving average of $360.11. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. The firm had revenue of $112.03 billion during the quarter, compared to analysts’ expectations of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business’s revenue for the quarter was up .4% on a year-over-year basis. During the same quarter in the previous year, the company earned $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 19.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be paid a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group’s payout ratio is presently 59.72%.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 1,169 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.19% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Bank of America reissued a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 20th. DA Davidson set a $512.00 price objective on UnitedHealth Group in a research report on Tuesday, July 21st. Wall Street Zen raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Weiss Ratings downgraded shares of UnitedHealth Group from a “hold (c)” rating to a “hold (c-)” rating in a research note on Tuesday, July 28th. Finally, Leerink Partners raised their price objective on shares of UnitedHealth Group from $400.00 to $462.00 and gave the company an “outperform” rating in a research note on Wednesday, June 17th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $456.56.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.